AMSBIO has signed an agreement with Genea Biocells (San Diego, USA) to become global distribution partner to the academic community for its groundbreaking skeletal muscle differentiation product range. Genea Biocells developed the world’s first protocol to robustly differentiate human pluripotent stem cells to skeletal muscle cells with high yields and without cell sorting or genetic manipulation (Caron et al. […]
New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the Way for Future Growth Resulting Cost Savings to be Reinvested Back into the Business CINCINNATI — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the realignment of its business structure aimed at […]
FARMINGDALE, N.Y. – EpiGentek, a NY-based biotechnology firm specializing in epigenetic research products and services, announced its technological and financial support for new skincare startup EpigenCare. William Lee, who served as an operations executive for a number of years at EpiGentek, spearheads EpigenCare’s venture as its CEO. EpiGentek will work in collaboration with EpigenCare to […]
SAN FRANCISCO — Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National Cancer Institute, along with agreements with research groups at three other academic and pharma institutions, to demonstrate the clinical utility of their immune-profiling assay, Cofactor Paragon. These research collaborations are centered […]
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the launch of a private placement of up to 4.74 million new shares to institutional investors in Europe. The price per share is set to EUR 1.40, based on a weighted average XETRA closing price of the Sygnis AG […]
Warminster, PA Brian Larkin, CEO of SP Industries, Inc. (SP) has announced the appointment of Martin Tricarico as Senior Vice President of Sales for SP Industries Scienceware and Ableware divisions. Tricarico who has an extensive leadership background in life sciences and related markets from start-ups to multinational corporations that include GE Healthcare, has been tapped […]
New website increases accessibility to leading-edge product range and latest information CORALVILLE, IA – As advocates for the genomics age, Integrated DNA Technologies (IDT), has launched a new version of its website designed to enhance support to researchers across the globe. The updated website features easy-to-find product information arranged by application and fast navigation – saving […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (the “Company”) and Integrated DNA Technologies (“IDT”) announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. IDT’s primary business is the manufacturing of […]
Originally released in 5um particle size, we are pleased to announce the availability of a new 3um version of Chiral ART Cellulose-SJ. Whether you want to buy this new item or you want to buy C18 reversed phase columns, you can do so right here on our website. And if you wanted to learn more about […]
Chiral Technologies Introduces CHIRALPAK® IH – The Newest Immobilized Chiral Selector from DAICEL Corporation WEST CHESTER, Pa. — Chiral Technologies announces the newest immobilized chiral stationary phase (CSP) from DAICEL, CHIRALPAK® IH. This new CSP, the immobilized version of DAICEL’s popular CHIRALPAK AS, provides greater solvent versatility, robustness, and loading capacity. The addition of this new […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

